Methods and Compositions to Identify Increased Risk of Breast Cancer by Detection of CPG Island Methylator Phenotype (CIMP)
The present invention is directed to kits and methods for identifying a female subject as having an increased risk of developing breast cancer, comprising detecting a CPG island methylator phenotype (CIMP) in nucleic acid of the subject.
Patents:US 20,100,124,742
Inventor(s):
SEEWALDT VICTORIA L [US]
Type of Offer:
Licensing
« More Medical Patents